| NOVAVAX INC. DL-,01 |
| USA |
| Gesundheit |
| US6700024010 / A2PKMZ |
| NVV1 (Frankfurt) |
| FRA:NVV1, ETR:NVV1, NVV1:GR |
| - |
| https://novavax.com/ |
|
Novavax Inc. is a biotechnology company specializi..
>Volltext.. |
| 1081.43 Mio. EUR |
| 635.36 Mio. EUR |
| 914.23 Mio. EUR |
| 387.91 Mio. EUR |
| 293.46 Mio. EUR |
| 1.83 EUR |
| 215.66 Mio. EUR |
| 239.44 Mio. EUR |
| -324.87 Mio. EUR |
| 1.8 |
| 14.12% |
| - |
| - |
| - |
| - |
| - |
| NOVAVAX |
| 14.01.26 |
|